Drug
Fxiii Concentrate
Fxiii Concentrate: highest development phase Phase 3, developed by CSL. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| FXIII Concentrate (Human) (FXIII) NCT00945906 | Phase 3 | Factor XIII Deficiency |
| FXIII Concentrate (Human) NCT00885742 | Phase 3 | Factor XIII Deficiency |
Latest
No recent events.
Follow Fxiii Concentrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.